Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 206 results.
User Information
Export Records
  1. 1.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 2.   Generation of HIV-1 primary isolates representative of plasma variants using the U87.CD4 cell line
  2. Heeregrave, E. J.; Ampofo, W. K.; Tetteh, J. K. A.; Ofori, M.; Ofori, S. B.; Shah, A. S.; Pollakis, G.; Paxton, W. A.
  3. Journal of Virological Methods. 2010, Nov; 169(2): 341-350.
  1. 3.   Reverse transcriptase in motion: Conformational dynamics of enzyme-substrate interactions
  2. Gotte, M.; Rausch, J. W.; March, B.; Sarafianos, S.; Le Grice, S. F. J.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2010, May; 1804(5): 1202-1212.
  1. 4.   In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity
  2. Jones, F. D.; Hughes, S. H.
  3. Virology. 2007, Apr; 360(2): 341-349.
  1. 5.   Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis
  2. Rausch, J. W.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2007, Jan; 35(1): 256-268.
  1. 6.   Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
  2. Deng, J. X.; Kelley, J. A.; Barchi, J. J.; Sanchez, T.; Dayam, R.; Pommier, Y.; Neamati, N.
  3. Bioorganic & Medicinal Chemistry. 2006, JUN 1; 14(11): 3785-3792.
  1. 7.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 8.   Asymmetric localization of Vangl2 and Fz3 indicate novel mechanisms for planar cell polarity in mammals
  2. Montcouquiol, M.; Sans, N.; Huss, D.; Kach, J.; Dickman, J. D.; Forge, A.; Rachel, R. A.; Copeland, N. G.; Jenkins, N. A.; Bogani, D.; Murdoch, J.; Warchol, M. E.; Wenthold, R. J.; Kelley, M. W.
  3. Journal of Neuroscience. 2006, MAY 10; 26(19): 5265-5275.
  1. 9.   Meeting report: Exploiting the Tumor Microenvironment for Therapeutics
  2. Melillo, G.; Semenza, G. L.
  3. Cancer Research. 2006, MAY 1; 66(9): 4558-4560.
  1. 10.   Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization
  2. McWilliams, M. J.; Julias, J. G.; Sarafianos, S. G.; Alvord, W. G.; Arnold, E.; Hughes, S. H.
  3. Virology. 2006, May; 348(2): 378-388.
  1. 11.   Prelamin A and lamin A appear to be dispensable in the nuclear lamina
  2. Fong, L. G.; Ng, J. K.; Lammerding, J.; Vickers, T. A.; Meta, M.; Cote, N.; Gavino, B.; Qiao, X.; Chang, S. Y.; Young, S. R.; Yang, S. H.; Stewart, C. L.; Lee, R. T.; Bennett, C. F.; Bergo, M. O.; Young, S. G.
  3. Journal of Clinical Investigation. 2006, MAR; 116(3): 743-752.
  1. 12.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 13.   Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide
  2. Chen, K. Q.; Iribarren, P.; Hu, J. Y.; Chen, J. H.; Gong, W. H.; Cho, E. H.; Lockett, S.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Biological Chemistry. 2006, FEB 10; 281(6): 3651-3659.
  1. 14.   Examining Ty3 polypurine tract structure and function by nucleoside analog interference
  2. Dash, C.; Marino, J. P.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2006, FEB 3; 281(5): 2773-2783.
  1. 15.   The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma
  2. Herranz, M.; Martin-Caballero, J.; Fraga, M. F.; Ruiz-Cabello, J.; Flores, J. M.; Desco, M.; Marquez, V.; Esteller, M.
  3. Blood. 2006, FEB 1; 107(3): 1174-1177.
  1. 16.   The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain,, RING finger, and an E2-binding site
  2. Chen, B.; Mariano, J.; Tsai, Y. C.; Chan, A. H.; Cohen, M.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 10; 103(2): 341-346.
  1. 17.   Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway
  2. Lee, H. S.; Bong, Y. S.; Moore, K. B.; Soria, K.; Moody, S. A.; Daar, I. O.
  3. Nature Cell Biology. 2006, JAN; 8(1): 55-63.
  1. 18.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
  1. 19.   A base-specific recognition signal in the 5 ' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments
  2. Tortorici, M. A.; Shapiro, R. A.; Patton, J. T.
  3. Rna-a Publication of the Rna Society. 2006, JAN; 12(1): 133-146.
  1. 20.   Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
  2. Feng, Y.; Zhu, Z. Y.; Xiao, X. D.; Choudhry, V.; Barrett, J. C.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2006, JAN; 5(1): 114-120.
  1. 21.   Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides
  2. Fisher, R. J.; Fivash, M. J.; Stephen, A. G.; Hagan, N. A.; Shenoy, S. R.; Medaglia, M. V.; Smith, L. R.; Worthy, K. M.; Simpson, J. T.; Shoemaker, R.; McNitt, K. L.; Johnson, D. G.; Hixson, C. V.; Gorelick, R. J.; Fabris, D.; Henderson, L. E.; Rein, A.
  3. Nucleic Acids Research. 2006 34(2): 472-484.
  1. 22.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 23.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 24.   LC-MS in metabonomics: Optimization of experimental conditions for the analysis of metabolites in human urine
  2. Waybright, T. J.; Van, Q. N.; Muschik, G. M.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Liquid Chromatography & Related Technologies. 2006 29(17): 2475-2497.
  1. 25.   Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: Implications on enteric neurodegeneration
  2. Surendran, S.; Kondapaka, S. B.
  3. Biochemical and Biophysical Research Communications. 2005, DEC 16; 338(2): 919-922.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel